US Stock MarketDetailed Quotes

INKT MiNK Therapeutics

Watchlist
  • 1.120
  • +0.151+15.61%
Close Jul 12 16:00 ET
  • 1.070
  • -0.050-4.46%
Post 19:56 ET
38.89MMarket Cap-1898P/E (TTM)

MiNK Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
41.78%-2.54M
16.45%-15.76M
31.48%-3.04M
25.03%-4.21M
10.25%-4.15M
-4.05%-4.37M
-47.09%-18.87M
-160.27%-4.43M
-60.61%-5.61M
-35.23%-4.63M
Net income from continuing operations
32.94%-3.81M
19.77%-22.46M
29.75%-5.46M
19.20%-5.12M
-1.38%-6.2M
26.89%-5.69M
7.35%-27.99M
-34.79%-7.77M
55.62%-6.33M
3.51%-6.11M
Operating gains losses
----
90.44%-266.78K
----
----
----
----
-685.00%-2.79M
----
----
----
Depreciation and amortization
17.83%53.83K
68.06%204.62K
41.23%53.57K
88.02%53.45K
83.36%51.91K
68.73%45.69K
56.17%121.75K
59.15%37.93K
40.15%28.43K
60.42%28.31K
Other non cash items
--4.44K
----
----
----
----
----
----
----
----
----
Change In working capital
75.96%620.81K
-66.95%2.9M
-51.88%1.27M
-1.38%-85.6K
-60.50%1.36M
-87.25%352.81K
134.64%8.77M
-20.71%2.63M
-113.84%-84.44K
556.92%3.45M
-Change in prepaid assets
36.57%-6.35K
182.71%245.59K
69.00%-11.08K
241.01%223.52K
-45.56%43.16K
94.50%-10.01K
-160.76%-296.95K
-425.02%-35.74K
-200.91%-158.51K
-82.62%79.28K
-Change in payables and accrued expense
74.73%-99.99K
-98.23%107.57K
-63.36%891.2K
-300.26%-969.15K
-56.48%581.12K
-121.57%-395.61K
2,808.98%6.09M
4,280.30%2.43M
1,619.19%483.94K
1,002.37%1.34M
-Change in other working capital
-4.12%727.14K
-14.57%2.54M
63.49%387.27K
261.04%660.03K
-63.72%738.26K
-32.05%758.42K
-14.23%2.98M
-92.72%236.88K
-196.43%-409.86K
837.99%2.03M
Cash from discontinued investing activities
Operating cash flow
41.78%-2.54M
16.45%-15.76M
31.48%-3.04M
25.03%-4.21M
10.25%-4.15M
-4.05%-4.37M
-47.09%-18.87M
-160.27%-4.43M
-60.61%-5.61M
-35.23%-4.63M
Investing cash flow
Cash flow from continuing investing activities
0
70.58%-73.56K
0
61.46%-23.04K
40.69%-37.02K
-13.5K
-0.43%-250.05K
-46,250.90%-127.84K
46.53%-59.8K
36.26%-62.41K
Net PPE purchase and sale
--0
70.58%-73.56K
--0
61.46%-23.04K
40.69%-37.02K
---13.5K
-0.43%-250.05K
-46,250.90%-127.84K
46.53%-59.8K
36.26%-62.41K
Cash from discontinued investing activities
Investing cash flow
--0
70.58%-73.56K
--0
61.46%-23.04K
40.69%-37.02K
---13.5K
-0.43%-250.05K
-46,250.90%-127.84K
46.53%-59.8K
36.26%-62.41K
Financing cash flow
Cash flow from continuing financing activities
1,597.17%5.01M
-161.68%-407.17K
-101.80%-2
497.57%2.95K
51.75%-75.7K
-48,637.74%-334.43K
-100.32%-155.6K
-100.00%111
-99.98%494
-103.60%-156.89K
Net issuance payments of debt
--5M
----
----
----
----
--0
----
----
----
----
Net common stock issuance
--0
-203.85%-477.64K
---2
--2
37.84%-97.72K
---379.92K
-100.39%-157.19K
--0
--0
---157.19K
Proceeds from stock option exercised by employees
-84.84%6.9K
4,317.93%70.47K
--0
497.17%2.95K
7,215.61%22.02K
6,503.19%45.5K
963.33%1.6K
--111
229.33%494
--301
Cash from discontinued financing activities
Financing cash flow
1,597.17%5.01M
-161.68%-407.17K
-101.80%-2
497.57%2.95K
51.75%-75.7K
-48,637.74%-334.43K
-100.32%-155.6K
-100.00%111
-99.98%494
-103.60%-156.89K
Net cash flow
Beginning cash position
-82.85%3.37M
-49.51%19.64M
-73.51%6.4M
-64.41%10.62M
-57.07%14.89M
-49.51%19.64M
1,345.06%38.89M
2,848.15%24.16M
1,699.80%29.85M
4,181.08%34.69M
Current changes in cash
152.28%2.46M
15.72%-16.24M
33.40%-3.04M
25.46%-4.23M
11.99%-4.26M
-12.36%-4.71M
-153.27%-19.27M
-111.97%-4.56M
-587.79%-5.67M
-680.77%-4.84M
Effect of exchange rate changes
49.43%-14.84K
-230.26%-25.25K
-87.82%4.31K
141.32%5.91K
-313.01%-6.12K
-539.77%-29.34K
14.71%19.39K
236.54%35.39K
-2.59%-14.29K
-79.37%2.88K
End cash Position
-60.94%5.82M
-82.85%3.37M
-82.85%3.37M
-73.51%6.4M
-64.41%10.62M
-57.07%14.89M
-49.51%19.64M
-49.51%19.64M
2,848.15%24.16M
1,699.80%29.85M
Free cash flow
41.96%-2.54M
17.16%-15.84M
33.40%-3.04M
25.42%-4.23M
10.66%-4.19M
-4.37%-4.38M
-46.20%-19.12M
-167.82%-4.56M
-57.29%-5.67M
-33.24%-4.69M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 41.78%-2.54M16.45%-15.76M31.48%-3.04M25.03%-4.21M10.25%-4.15M-4.05%-4.37M-47.09%-18.87M-160.27%-4.43M-60.61%-5.61M-35.23%-4.63M
Net income from continuing operations 32.94%-3.81M19.77%-22.46M29.75%-5.46M19.20%-5.12M-1.38%-6.2M26.89%-5.69M7.35%-27.99M-34.79%-7.77M55.62%-6.33M3.51%-6.11M
Operating gains losses ----90.44%-266.78K-----------------685.00%-2.79M------------
Depreciation and amortization 17.83%53.83K68.06%204.62K41.23%53.57K88.02%53.45K83.36%51.91K68.73%45.69K56.17%121.75K59.15%37.93K40.15%28.43K60.42%28.31K
Other non cash items --4.44K------------------------------------
Change In working capital 75.96%620.81K-66.95%2.9M-51.88%1.27M-1.38%-85.6K-60.50%1.36M-87.25%352.81K134.64%8.77M-20.71%2.63M-113.84%-84.44K556.92%3.45M
-Change in prepaid assets 36.57%-6.35K182.71%245.59K69.00%-11.08K241.01%223.52K-45.56%43.16K94.50%-10.01K-160.76%-296.95K-425.02%-35.74K-200.91%-158.51K-82.62%79.28K
-Change in payables and accrued expense 74.73%-99.99K-98.23%107.57K-63.36%891.2K-300.26%-969.15K-56.48%581.12K-121.57%-395.61K2,808.98%6.09M4,280.30%2.43M1,619.19%483.94K1,002.37%1.34M
-Change in other working capital -4.12%727.14K-14.57%2.54M63.49%387.27K261.04%660.03K-63.72%738.26K-32.05%758.42K-14.23%2.98M-92.72%236.88K-196.43%-409.86K837.99%2.03M
Cash from discontinued investing activities
Operating cash flow 41.78%-2.54M16.45%-15.76M31.48%-3.04M25.03%-4.21M10.25%-4.15M-4.05%-4.37M-47.09%-18.87M-160.27%-4.43M-60.61%-5.61M-35.23%-4.63M
Investing cash flow
Cash flow from continuing investing activities 070.58%-73.56K061.46%-23.04K40.69%-37.02K-13.5K-0.43%-250.05K-46,250.90%-127.84K46.53%-59.8K36.26%-62.41K
Net PPE purchase and sale --070.58%-73.56K--061.46%-23.04K40.69%-37.02K---13.5K-0.43%-250.05K-46,250.90%-127.84K46.53%-59.8K36.26%-62.41K
Cash from discontinued investing activities
Investing cash flow --070.58%-73.56K--061.46%-23.04K40.69%-37.02K---13.5K-0.43%-250.05K-46,250.90%-127.84K46.53%-59.8K36.26%-62.41K
Financing cash flow
Cash flow from continuing financing activities 1,597.17%5.01M-161.68%-407.17K-101.80%-2497.57%2.95K51.75%-75.7K-48,637.74%-334.43K-100.32%-155.6K-100.00%111-99.98%494-103.60%-156.89K
Net issuance payments of debt --5M------------------0----------------
Net common stock issuance --0-203.85%-477.64K---2--237.84%-97.72K---379.92K-100.39%-157.19K--0--0---157.19K
Proceeds from stock option exercised by employees -84.84%6.9K4,317.93%70.47K--0497.17%2.95K7,215.61%22.02K6,503.19%45.5K963.33%1.6K--111229.33%494--301
Cash from discontinued financing activities
Financing cash flow 1,597.17%5.01M-161.68%-407.17K-101.80%-2497.57%2.95K51.75%-75.7K-48,637.74%-334.43K-100.32%-155.6K-100.00%111-99.98%494-103.60%-156.89K
Net cash flow
Beginning cash position -82.85%3.37M-49.51%19.64M-73.51%6.4M-64.41%10.62M-57.07%14.89M-49.51%19.64M1,345.06%38.89M2,848.15%24.16M1,699.80%29.85M4,181.08%34.69M
Current changes in cash 152.28%2.46M15.72%-16.24M33.40%-3.04M25.46%-4.23M11.99%-4.26M-12.36%-4.71M-153.27%-19.27M-111.97%-4.56M-587.79%-5.67M-680.77%-4.84M
Effect of exchange rate changes 49.43%-14.84K-230.26%-25.25K-87.82%4.31K141.32%5.91K-313.01%-6.12K-539.77%-29.34K14.71%19.39K236.54%35.39K-2.59%-14.29K-79.37%2.88K
End cash Position -60.94%5.82M-82.85%3.37M-82.85%3.37M-73.51%6.4M-64.41%10.62M-57.07%14.89M-49.51%19.64M-49.51%19.64M2,848.15%24.16M1,699.80%29.85M
Free cash flow 41.96%-2.54M17.16%-15.84M33.40%-3.04M25.42%-4.23M10.66%-4.19M-4.37%-4.38M-46.20%-19.12M-167.82%-4.56M-57.29%-5.67M-33.24%-4.69M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday+0.91%